The quiet end of Calder Vale Peptides of Skipton
A proper account of an operation that existed, and of what closing it cost.
The archive — 2024
Page 42 of 68 of this archive, newest first.
Independent analysis puts a QST cagrilintide lot at 98.4%, against 96.0% on the certificate
The supplier has not disputed the finding. It has not explained the gap either.
STEP 2 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
What the new Nigeria guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What we are not saying about anybody in this trade
None of what this piece asks for is commercially sensitive, and all of it is already known to whoever released the batch.
Quadrupole, time-of-flight, orbital trap: what each class can and cannot see
Parts per million sound impressive until they are converted into daltons at the molecular weight of the thing being measured.
Germany caps tirzepatide prescribing to 11 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A supplier suspends shipping to Ireland after 18 consecutive customs detentions
The route did not close because of a rule about peptides.
A supplier suspends shipping to Poland after 20 consecutive customs detentions
The route did not close because of a rule about peptides.
Maximum tolerated is not maximum approved
A plateau at an intermediate dose and a plateau at the maximum dose look identical from the outside and mean different things.
What the cagrilintide schedule assumes about a person it has never met
What the published pharmacokinetics permit, what the labels state, and where the two diverge.
What the placebo arms of the withdrawal trials actually tell us
Three randomised withdrawal designs have tested what happens when treatment stops. Their results are consistent and they are consistently misreported.
Inspectors cite the relabeller trading as Vantris Bio over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The 13-day notice: how a compounding wind-down works in Turkey
The document is four pages. Three of them are about dates.
FLOW extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Quadrupole, time-of-flight, orbital trap: what each class can and cannot see
Every instrument specification quoted in an advertisement is a best case obtained on a calibration mixture, not on a submitted vial.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
Ireland pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
Xi'an export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Mexico declines to reimburse dulaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Twenty-eight days is a number from somebody else’s product
Every degradation pathway accelerates by orders of magnitude on reconstitution, because the solvent that lyophilisation removed is the reagent most of them need.
Why "muscle-sparing" is a marketing term and not a measurement
The rule that a quarter of weight lost is lean tissue has been in textbooks for decades and does not survive close reading.
The United Arab Emirates pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What a 14% rise in coupling-reagent prices does to a 15 mg vial
Follow the resin, not the catalogue.
What the paperwork is for, and who it was designed to protect
The header identifies the batch, the table records the tests, and the footer says who is answerable. Two of the three are usually incomplete.
Holding the dose before surgery: for whom, for how long
This is the single interaction with ordinary medical care that patients most need to disclose, and it is the one most often not asked about.
The consolidator trading as Meridian Freight Partners closes after 6 years
A proper account of an operation that existed, and of what closing it cost.